Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
February 22, 2022
Patent Application Number
16076307
Date Filed
February 15, 2017
Patent Citations Received
Patent Primary Examiner
Patent abstract
The present disclosure provides certain compounds that are histone methyltransferases G9a and/or GLP inhibitors and are therefore useful for the treatment of diseases treatable by inhibition of G9a and/or GLP such as cancers and hemoglobinpathies such as beta-thalassemia and sickle cell disease. Also provided are pharmaceutical compositions containing such compounds as well as processes and intermediates for preparing such compounds.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
